Comparison of SARS-CoV-2 variants of concern in primary human nasal cultures demonstrates Delta as most cytopathic and Omicron as fastest replicatingResearch Article Published on 2024-04-132024-09-05 Journal: mBio [Category] update2024, [키워드] COVID-19 dsRNA primary nasal cultures SARS-CoV-2 spike cleavage variants of concern [DOI] 10.1128/mbio.03129-23 PMC 바로가기 [Article Type] Research Article
SARS-CoV-2 genomic surveillance and reliability of PCR single point mutation assay ( SNPsig® SARS-CoV-2 EscapePLEX CE ) for the rapid detection of variants of concern in CameroonResearch Article Published on 2024-04-062024-09-05 Journal: Heliyon [Category] update2024, [키워드] Cameroon SARS-CoV-2 SNPsig®EscapePLEX CE variants of concern [DOI] 10.1016/j.heliyon.2024.e29243 PMC 바로가기 [Article Type] Research Article
Host and viral determinants of airborne transmission of SARS-CoV-2 in the Syrian hamsterMicrobiology and Infectious Disease Published on 2024-02-282024-09-05 Journal: eLife [Category] update2024, [키워드] airborne Compelling fundamental SARS-CoV-2 Syrian hamster Transmission variants of concern virus kinetics viruses [DOI] 10.7554/eLife.87094 PMC 바로가기 [Article Type] Microbiology and Infectious Disease
Within-host evolution of SARS-CoV-2: how often are de novo mutations transmitted from symptomatic infections?Research Article Published on 2024-02-212024-09-05 Journal: Virus Evolution [Category] update2024, [키워드] bottleneck dynamics COVID-19 de novo mutations evolution of immune escape SARS-CoV-2 Transmission dynamics variants of concern viral evolution viral evolvability virus evolutionary dynamics virus life history evolution [DOI] 10.1093/ve/veae006 PMC 바로가기 [Article Type] Research Article
A Broad-Spectrum Multi-Antigen mRNA/LNP-Based Pan-Coronavirus Vaccine Induced Potent Cross-Protective Immunity Against Infection and Disease Caused by Highly Pathogenic and Heavily Spike-Mutated SARS-CoV-2 Variants of Concern in the Syrian Hamster ModelArticle Published on 2024-02-152024-09-05 Journal: bioRxiv [Category] update2024, [키워드] CD4+ T cells CD8+ T cells COVID-19 cross-protective pan-coronavirus vaccine SARS-CoV-2 variants of concern [DOI] 10.1101/2024.02.14.580225 PMC 바로가기 [Article Type] Article
Pseudotyped virus infection of multiplexed ACE2 libraries reveals SARS-CoV-2 variant shifts in receptor usageArticle Published on 2024-02-142024-09-05 Journal: bioRxiv [Category] update2024, [키워드] 293T cells ACE2 genetics Multiplex assay Pseudotyped virus SARS-CoV-2 variants of concern virus entry virus receptors [DOI] 10.1101/2024.02.13.580056 PMC 바로가기 [Article Type] Article
Comparison of analytical performance and economic value of two biosurveillance methods for tracking SARS-COV-2 variants of concernResearch Article Published on 2024-02-112024-09-05 Journal: Microbiology Spectrum [Category] update2024, [키워드] genotyping NGS PCR SARS-CoV-2 Sequencing Surveillance variants of concern [DOI] 10.1128/spectrum.03484-23 PMC 바로가기 [Article Type] Research Article
In-hospital mortality during the wild-type, alpha, delta, and omicron SARS-CoV-2 waves: a multinational cohort study in the EuCARE projectArticle Published on 2024-02-022024-09-05 Journal: The Lancet Regional Health - Europe [Category] update2024, [키워드] COVID-19 in-hospital mortality SARS-CoV-2 variants of concern [DOI] 10.1016/j.lanepe.2024.100855 PMC 바로가기 [Article Type] Article
SARS-CoV-2 Specific Nanobodies Neutralize Different Variants of Concern and Reduce Virus Load in the Brain of h-ACE2 Transgenic MiceArticle Published on 2024-01-252024-09-05 Journal: Viruses [Category] update2024, [키워드] intranasal treatment nanobodies SARS-CoV-2 variants of concern Virus neutralization [DOI] 10.3390/v16020185 PMC 바로가기 [Article Type] Article
Hybrid Immunity from Gam-COVID-Vac Vaccination and Natural SARS-CoV-2 Infection Confers Broader Neutralizing Activity against Omicron Lineage VOCs Than Revaccination or ReinfectionArticle Published on 2024-01-062024-09-05 Journal: Vaccines [Category] update2024, [키워드] antibody COVID-19 Hybrid immunity neutralization breadth variants of concern virus escape [DOI] 10.3390/vaccines12010055 PMC 바로가기 [Article Type] Article